News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TAP Biosystems Release: New Webinar Compares 2D And 3D Cell Culture Technologies With Data Showing How To Improve Oncology And Toxicology Screening


1/30/2014 9:11:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cambridge, UK: TAP Biosystems, a leading supplier of innovative cell culture and fermentation systems for life science applications, today announced that it will be co-presenting a new 3D cell culture webinar with BioTek Instruments on Thursday, Feb 27, 2014 at 12:00 PM EST. The live event will offer free access to new scientific presentations demonstrating the benefits of using 3D cell culture including RAFT™ 3D collagen-based technology in oncology research and toxicology screening.

Two 3D cell culture experts, Brad Larson, Principal Scientist at BioTek Instruments, and Dr Grant Cameron, TAP Biosystems’ RAFT Development Director will be presenting data derived from oncology and toxicology studies. They will discuss the capability of two types of 3D cell culture methods, incorporating either collagen hydrogels with RAFT 3D cell culture technology or a spheroid method of 3D cell culture. Both specialists will provide data generated using microplate-based assays and fluorescence imaging to show that cells cultured in 3D maintain greater viability and function over extended time periods compared to 2D cell culture, and will explain how using 3D cell culture may provide better correlation to clinical testing in oncology and long-term cytotoxicity studies.

To join the webinar, scientists simply need to register at:

http://www.tapbiosystems.com/RAFT_webinar/RAFToncwebinar_BioTekPR.htm

Dr Grant Cameron, TAP Biosystems’ RAFT Development Director stated: “Improving drug efficacy and eliminating unexpected cytotoxicity issues prior to clinical trials by making the assays in early drug discovery more biological relevant has been a challenge in the biopharm industry for the past decade. 3D cell culture offers a solution to this issue.” Cameron continued: “I am therefore delighted to be hosting a webinar alongside Brad Larson in which we’ll demonstrate that cells cultured in 3D provide better mimics of cellular function within living tissue and I look forward to discussing how incorporating 3D cell culture processes into oncology and toxicology screening programmes can contribute to providing more accurate and clinically relevant data.”

For Further Information Contact:

Matthew Walker, Head of Communications, TAP Biosystems, York Way, Royston, Hertfordshire, SG8 5WY, UK. Tel: +44 (0) 1763 227200
Fax: +44 (0) 1763-227201 Email: matthew.walker@tapbiosystems.com
Web: www.tapbiosystems.com Twitter: @TAPBiosystems

Editor Contact:
Dr Sue Pearson, Director, International Science Writer, PO Box 170, Hitchin, Hertfordshire, SG5 3GD, UK.
Tel/Fax + 44 (0) 1462-635327 Email: sue.pearson@internationalsciencewriter.com
Web: www.internationalsciencewriter.com Twitter: @isciencewriter

About TAP Biosystems

TAP Biosystems (A Sartorius Company) is a leading global provider of automated cell culture and fermentation systems for life science research, development and production.

TAP's systems are in use worldwide at pharmaceutical, biotechnology and academic laboratories, supporting bioprocess development and GMP manufacture of biologics and cell therapies, as well as discovery and stem cell research programmes.

Founded in 1987, the company has offices in the UK and USA, and an extensive network of distributors in Europe and Asia offering pre- and post-sales support.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES